TL;DR
Humana Inc. is in advanced talks to acquire Sarasota-based primary care network MaxHealth for nearly $1 billion. The deal would bolster Humana's footprint in the critical Florida Medicare...
TL;DR
Eli Lilly announced its acquisition of Orna Therapeutics for up to $2.4 billion in cash on February 9, 2026, gaining access to Orna's circular RNA platform for in vivo cell engineering. The...
TL;DR
Novartis is strategically prioritizing early-stage pipeline assets and clinical-stage candidates for acquisition, a shift driven by intense competition and prohibitive valuations for...
TL;DR
Mubadala Capital has exited its minority stake in Arcadia Consumer Healthcare, with majority owner Bansk Group assuming full control through a continuation vehicle backed by Coller Capital and...
TL;DR
Merck & Co. terminated acquisition talks with Revolution Medicines for a potential $28-32 billion deal, causing Revolution's stock to plunge 20%. The collapse stemmed from a valuation...
TL;DR
BioCryst Pharmaceuticals Inc. completed its all-cash acquisition of Astria Therapeutics Inc. for $700 million on January 23, 2026. This transaction significantly enhances BioCryst's leadership...
The Clorox Company has agreed to acquire GOJO Industries, the Ohio-based manufacturer of Purell hand sanitizer and skin health products, in an all-cash transaction valued at $2.25 billion. The deal...
TL;DR
Former executives of an unnamed health tech company that went public via a SPAC merger have agreed to a $10 million settlement to resolve investor lawsuits. The claims alleged executives...
TL;DR
GSK is set to acquire clinical-stage biotech Rapt Therapeutics for $2.2 billion in equity, or $58 per share in cash, with a net cash commitment of $1.9 billion. This acquisition grants GSK...
TL;DR
AstraZeneca's CFO outlined a disciplined M&A strategy, prioritizing bolt-on acquisitions under $5 billion in oncology and rare diseases, while actively scouting for preclinical assets in...
